NUWE NUWELLIS INC

Nuwellis, Inc. To Announce Second Quarter 2022 Financial Results on August 9, 2022

Nuwellis, Inc. To Announce Second Quarter 2022 Financial Results on August 9, 2022

MINNEAPOLIS, July 14, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its second quarter 2022 financial results will be released on Tuesday, August 9, 2022. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview. To access the live webcast, please visit , or the Investors page of the Nuwellis website at . Alternatively, you may access the live conference call by registering through . An audio archive of the webcast will be available following the call on the Investors page at .

About Nuwellis

Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, MN, with a wholly-owned subsidiary in Ireland.

Investor Contacts:

George Montague, CFA

Chief Financial Officer, Nuwellis, Inc.

Matt Bacso, CFA

Gilmartin Group LLC

Media Contact:

Sarah Lundberg

Health+Commerce



EN
14/07/2022

Underlying

NUWENUWELLIS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NUWELLIS INC

 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offerin...

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 49,999,995 shares of Com...

June 10, 2025 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offerin...

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering MINNEAPOLIS, June 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the pricing of a public offering of 406,755 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 43,478,259 shares of Common Stock and Series B Warrants to purchase up to ...

June 9, 2025 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Busine...

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights MINNEAPOLIS, May 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. First Quarter 2025 and Recent Business Highlights Nuwellis continued to advance its strategic priorities during the first quarter, delivering growth in customer categories and strengthening the foundation for broade...

May 13, 2025 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Prod...

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency Strategic agreement is expected to reduce costs, preserve expertise, and streamline operations. WHOWHATWHEREWHENWHYNuwellis, Inc. (Nasdaq: NUWE) and KDI Precision ManufacturingOutsourcing manufacturing and assembly of key Aquadex product components.Manufacturing operations will transition to KDI’s facility.May 9, 2025To strengthen operational efficiency, preserve product expertise, and reduce costs. MINNEAPOLIS, May 12, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE),...

May 12, 2025 1 EN
 PRESS RELEASE
Free
NUWE NUWELLIS INC

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Ho...

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems The Company has 47 Pediatric Centers utilizing Aquadex MINNEAPOLIS, May 08, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced a meaningful step forward for children facing fluid overload with the recent expansion of its Aquadex SmartFlow® therapy into two additional pediatric centers across the Southeastern United States. The company now has 47 pediatric centers that have adopted Aq...

May 8, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch